PMID- 38352295
OWN - NLM
STAT- PubMed-not-MEDLINE
LR  - 20240215
IS  - 2352-0132 (Electronic)
IS  - 2096-6296 (Print)
IS  - 2352-0132 (Linking)
VI  - 11
IP  - 1
DP  - 2024 Jan
TI  - Comparison of the performance of four screening tools for sarcopenia in patients 
      with chronic liver disease.
PG  - 3-10
LID - 10.1016/j.ijnss.2023.12.014 [doi]
AB  - OBJECTIVES: Early identification of sarcopenia in patients with chronic liver 
      disease is crucial for patient management and prevention of severe complications. 
      We aimed to assess the effectiveness of Ishii score, Strength, Assistance with 
      Walking, Rise from a Chair, Climb Stairs and Falls (SARC-F), SARC-F and Calf 
      Circumference (SARC-CalF), and Mini Sarcopenia Risk Assessment-7 (MSRA-7) to 
      screen sarcopenia in patients with chronic liver disease. METHODS: This 
      prospective study included patients with chronic liver disease in the infectious 
      department of a tertiary hospital in Sichuan, China. Ishii score, SARC-F, 
      SARC-CalF, and MSRA-7 were used to screen for sarcopenia risk. Sarcopenia was 
      diagnosed according to the Asian Myometriosis Working Group (AWGS) 2019, which 
      was used as the gold standard to compare the performance of the four screening 
      tools. We completed clinical registration on the Chinese Clinical Trial 
      Registration website (ChiCTR2100043910). RESULTS: A total of 366 patients with 
      chronic liver disease (22.4% women, mean age 48.96 +/- 11.88 years) were evaluated. 
      Based on the AWGS 2019 standard, the prevalence of sarcopenia in patients with 
      chronic liver disease was 17.5%. Among all participants, receiver operating 
      characteristic (ROC) produced an area under the curve (AUC) of 0.82 for Ishii 
      score (sensitivity 85.94%, specificity 78.15%), 0.53 for SARC-F (sensitivity 
      6.25%, specificity 99.34%), 0.64 for SARC-CalF (sensitivity 45.31%, specificity 
      83.11%), and 0.55 for MSRA-7 (sensitivity 87.50%, specificity 22.85%). Based on 
      AUC, decision curve analysis, and calibration curves, we concluded that Ishii 
      score was the most accurate screening tool and was superior to the other tools. 
      CONCLUSIONS: Ishii score is more suitable for screening sarcopenia in patients 
      with chronic liver disease than the SARC-F, SARC-CalF, and MSRA-7, based on the 
      AWGS 2019 criteria. Nursing professionals can use Ishii score as a clinical tool 
      to screen for sarcopenia in patients with chronic liver disease, providing an 
      indication cue for the final diagnosis of sarcopenia, improving diagnostic 
      efficiency, and enabling early identification and prevention of complications 
      resulting from sarcopenia.
CI  - (c) 2024 The Authors.
FAU - Yu, Ting
AU  - Yu T
AD  - Department of Evidence-based Nursing Center, West China Hospital, Sichuan 
      University/West China School of Nursing, Sichuan University, Chengdu, China.
AD  - Department of Nursing, West China Hospital, Sichuan University/West China School 
      of Nursing, Sichuan University, Chengdu, China.
FAU - Liu, Shanshan
AU  - Liu S
AD  - Department of Evidence-based Nursing Center, West China Hospital, Sichuan 
      University/West China School of Nursing, Sichuan University, Chengdu, China.
AD  - Department of Nursing, West China Hospital, Sichuan University/West China School 
      of Nursing, Sichuan University, Chengdu, China.
FAU - Zhao, Jing
AU  - Zhao J
AD  - Center of Infectious Diseases, West China Hospital, Sichuan University/West China 
      School of Nursing, Sichuan University, Chengdu, China.
FAU - Jiang, Yan
AU  - Jiang Y
AD  - Department of Evidence-based Nursing Center, West China Hospital, Sichuan 
      University/West China School of Nursing, Sichuan University, Chengdu, China.
AD  - Department of Nursing, West China Hospital, Sichuan University/West China School 
      of Nursing, Sichuan University, Chengdu, China.
FAU - Deng, Rong
AU  - Deng R
AD  - Center of Infectious Diseases, West China Hospital, Sichuan University/West China 
      School of Nursing, Sichuan University, Chengdu, China.
LA  - eng
PT  - Journal Article
DEP - 20231231
PL  - China
TA  - Int J Nurs Sci
JT  - International journal of nursing sciences
JID - 101660887
PMC - PMC10859570
OTO - NOTNLM
OT  - Chronic liver disease
OT  - Ishii score
OT  - Risk assessment
OT  - Sarcopenia
OT  - Screening
COIS- The authors declare that they have no conflicts of interest.
EDAT- 2024/02/14 06:43
MHDA- 2024/02/14 06:44
PMCR- 2023/12/31
CRDT- 2024/02/14 03:52
PHST- 2023/09/18 00:00 [received]
PHST- 2023/12/20 00:00 [revised]
PHST- 2023/12/29 00:00 [accepted]
PHST- 2024/02/14 06:44 [medline]
PHST- 2024/02/14 06:43 [pubmed]
PHST- 2024/02/14 03:52 [entrez]
PHST- 2023/12/31 00:00 [pmc-release]
AID - S2352-0132(23)00156-4 [pii]
AID - 10.1016/j.ijnss.2023.12.014 [doi]
PST - epublish
SO  - Int J Nurs Sci. 2023 Dec 31;11(1):3-10. doi: 10.1016/j.ijnss.2023.12.014. 
      eCollection 2024 Jan.